FDA Drug information
Regadenoson
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Regadenoson REGADENOSON .08 mg/mL Almaject, Inc.
- Regadenoson REGADENOSON .08 mg/mL Apotex Corp.
- Regadenoson REGADENOSON .08 mg/mL Baxter Healthcare Corporation
- Regadenoson REGADENOSON .08 mg/mL Eugia US LLC
- Regadenoson REGADENOSON .08 mg/mL Gland Pharma Limited
- Regadenoson REGADENOSON .08 mg/mL Meitheal Pharmaceuticals Inc.
- Regadenoson REGADENOSON .4 mg/5mL Mylan Institutional LLC
- Regadenoson REGADENOSON ANHYDROUS .08 mg/mL Dr. Reddy's Laboratories Inc.
- Regadenoson REGADENOSON ANHYDROUS .08 mg/mL Hikma Pharmaceuticals USA Inc.
- Regadenoson REGADENOSON ANHYDROUS .08 mg/mL Hospira, Inc.
- Regadenoson REGADENOSON ANHYDROUS .08 mg/mL International Medication Systems, Limited
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.